Value of FDG PET/CT in Patient Management and Outcome of Skeletal and Soft Tissue Sarcomas
- 1 July 2015
- journal article
- review article
- Published by Elsevier in PET Clinics
- Vol. 10 (3) , 375-393
Abstract
No abstract availableKeywords
This publication has 128 references indexed in Scilit:
- PET-Negative Gastrointestinal Stromal TumorsCase Reports in Oncology, 2013
- FDG PET/CT in Initial Staging of Adult Soft-Tissue SarcomaSarcoma, 2012
- The efficacy of PET-CT for predicting the malignant potential of gastrointestinal stromal tumorsSurgery Today, 2012
- Extraskeletal myxoid chondrosarcoma: tumor response to sunitinibClinical Sarcoma Research, 2012
- 18F-Fluorodeoxyglucose positron emission tomography in evaluating treatment response to imatinib or other drugs in gastrointestinal stromal tumors: a systematic reviewClinical Imaging, 2012
- CASE REPORT: The CT and 18F‐FDG PET/CT appearance of primary renal malignant fibrous histiocytomaJournal of Medical Imaging and Radiation Oncology, 2010
- Pediatric genitourinary tumorsCurrent Opinion in Oncology, 2010
- Early monitoring of external radiation therapy by [18F]-fluoromethylcholine positron emission tomography and 3-T proton magnetic resonance spectroscopy: an experimental study in a rodent rhabdomyosarcoma modelNuclear Medicine and Biology, 2010
- Molecular Target Modulation, Imaging, and Clinical Evaluation of Gastrointestinal Stromal Tumor Patients Treated with Sunitinib Malate after Imatinib FailureClinical Cancer Research, 2009
- Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal TumorsNew England Journal of Medicine, 2002